Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2022 ∙ Xu, B. Zhu, Y.
A systematic review and meta-analysis of the factors associating the willingness of Chinese community residents to receive COVID-19 vaccine
Western Pacific China All age groups COVID-19 Acceptance
Rating:
Not applicable
2022 ∙ Sulaiman, S. K. Musa, M. S. Tsiga-Ahmed, F. I. Dayyab, F. M. Sulaiman, A. K. Bako, A. T.
A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs)
All age groups Parents/caregivers Low and Middle Income Countries Malaria Acceptance
Rating:
Not applicable
2022 ∙ Malik, S. A. Modarage, K. Goggolidou, P.
A systematic review assessing the effectiveness of COVID-19 mRNA vaccines in chronic kidney disease (CKD) individuals
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Higdon, M. M. Wahl, B. Jones, C. B. Rosen, J. G. Truelove, S. A. Baidya, A. Nande, A. A. ShamaeiZadeh, P. A. Walter, K. K. Feikin, D. R. Patel, M. K. Deloria Knoll, M. Hill, A. L.
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Chun, H. M. Milligan, K. Agyemang, E. Ford, N. Rangaraj, A. Desai, S. Wilder-Smith, A. Vitoria, M. Zulu, I.
A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIV
All age groups COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Joseph, L. Lavis, A. Greenfield, S. Boban, D. Jose, P. Jeemon, P. Manaseki-Holland, S.
A systematic review of home-based records in maternal and child health for improving informational continuity, health outcomes, and perceived usefulness in low and middle-income countries
All age groups Parents/caregivers Pregnant women Healthcare workers Low and Middle Income Countries Coverage Acceptance
Rating:
Not applicable
2022 ∙ Mungall, B. A. Hoet, B. Nieto Guevara, J. Soumahoro, L.
A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children
Newborn Children Adolescents Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Goulden, B. Chua, N. Parker, E. Giles, I.
A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic drugs in utero
Newborn Tuberculosis Rotavirus Safety
Rating:
Critically low
2022 ∙ Chua, N. Parker, E. Giles, I. Goulden, B.
A systematic review of live vaccine outcomes in infants exposed to biologic disease modifying anti-rheumatic medications (DMARDs) in-utero
Newborn Tuberculosis Mumps Measles Rubella Rotavirus Safety Administration
Rating:
Critically low
2022 ∙ Teerawattananon, Y. Anothaisintawee, T. Pheerapanyawaranun, C. Botwright, S. Akksilp, K. Sirichumroonwit, N. Budtarad, N. Isaranuwatchai, W.
A systematic review of methodological approaches for evaluating real-world effectiveness of COVID-19 vaccines: Advising resource-constrained settings
All age groups Healthcare workers Low and Middle Income Countries COVID-19 Efficacy/effectiveness
Rating:
Not applicable
Loading...